Relapsed/refractory AML treatment by Pharmacoscopy-Identified Drugs, a randomized phase-2 clinical trial (PHRT RAPID) – PHRT

Project

Relapsed/refractory AML treatment by Pharmacoscopy-Identified Drugs, a randomized phase-2 clinical trial (PHRT RAPID)

The lay summary for this project is work-in-progress.

Clinical Trial

Co-Investigators

Prof. Dr. med. Markus Manz
PD Dr. med. Alexandre Theocharides

Consortium

Status

In Progress

8th Call, Clinical Trial

Funded by